RLS — RLS Global AB Share News
0.000.00%
- SEK35.62m
- SEK31.05m
- SEK1.20m
Brief: RLS Global Completes Directed New Share Issue Of 7.5 Mln Shares, Raising Proceeds Of SEK 50 Mln
Brief: RLS Global Signs Agreement With Onemed
Brief: RLS Global Q2 EBIT Loss Narrows To SEK 5.8 Million
Brief: RLS Global: Chlorasolv Receives CE Marking And Is Cleared For Commercial Launch In EU
Brief: RLS Global Q4 Operating Loss Narrows To SEK 5.9 Million
Brief: Rls Global July-Sept Operating Loss Widens To SEK 4.9 Million
Brief: RLS Global: Gets Approval For New Clinical Study Of ChloraSolv
Brief: RLS Global Q2 Operating Loss Narrows To SEK 4.8 Million
Brief: RLS Global Says Gets Information From Gothenburg Disctrict Court About Claim From Karin Bergquist
Brief: Rls Global AB Signs Distribution Agreement With A Dental Company
Brief: RLS Global Q1 Operating Loss Slightly Widens To SEK 4.8 Million
Brief: Rls Global Q4 Operating Loss at Sek 6.3 Million
Brief: RLS Global July-September Operating Loss Widens To SEK 3.3 Mln
Brief: RLS Global: Peter Hentschel proposed as Chairman
Brief: Biotech Capital says unit Bioimpact enters into license agreement with RLS Global
Brief: RLS Global: rights issue oversubscribed, proceeds of SEK 33.6 mln
Brief: RLS Global: Swiss company Regedent takes over global launch of Perisolv